Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

AstraZeneca AZ

AZ’s COPD triple data sets up market clash with GSK

KRONOS trial showed significant improvements in lung function tests over two-drug combos

Joel Colwell moves from Sanofi to J+D Consulting

He will support the firm’s senior team across their projects

McCann Health appoints global chief operating officer

Linda Szyper will take responsibility for optimising the company’s network

- PMLiVE

Pfizer and IBM’s tech-enabled ‘Parkinson’s house’

Pharma firm looks to technology to help it unlock the doors to breakthrough treatments

Biogen Idec building

Biogen cuts $217m deal for Karyopharm neurology drug

The biotech hopes to begin phase I trials of KPT-350 by the end of the year

- PMLiVE

Takeda and Zinfandel abandon Alzheimer’s drug

Pioglitazone failed to show therapeutic improvements in late-stage testing

- PMLiVE

Lucid present their ambitious plans to spread their magic across the industry

Lucid held their first breakfast meeting with top industry recruiters from across the UK to discuss their plans for expansion and recruitment for the year ahead. CEO and Co-Founder Dennis...

Lucid Group Communications Limited

- PMLiVE

Ogilvy appoints joint managing director of brand promotion and digital

Morten Frederiksen succeeds Caroline Howe

- PMLiVE

emotive partners with Rare Disease UK for public awareness campaign

Will launch the campaign ahead of next month's Rare Disease Day

- PMLiVE

W2O appoints Jennifer Gottlieb as president

She will take responsibility for W2O wcg, W2O twist and W2O pure

- PMLiVE

The shifting healthcare landscape

Global healthcare is facing massive disruption. Pressures such as an ‘always on’ social media and the new opportunities presented by partnership and collaboration with developers of ground-breaking technologies are contributing...

- PMLiVE

Novartis negotiates ex-US rights to Spark gene therapy

Strikes $170m deal for Luxturna

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links